PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity

Parasite Immunology

Volumn 27, Issue 1-2, 2005, Pages 45-53

  Colley, Daniel G ^a   Sasser, L E ^a   Reed, A M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

DC; Immunoregulation; Schistosomiasis; T lymphocytes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; LIGAND; MEMBRANE PROTEIN; PROGRAMMED DEATH 1 PROTEIN; PROGRAMMED DEATH LIGAND 2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL MODEL; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED CBA; SCHISTOSOMIASIS MANSONI;

EID: 17144409086     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00742.x     Document Type: Article

References (72)

1. Stadecker MJ. The development of granulomas in schistosomiasis: genetic backgrounds, regulatory pathways, and specific egg antigen responses that influence the magnitude of disease. Microbes Infect 1999; 1: 505-510.
2. Boros DL. T helper cell populations, cytokine dynamics, and pathology of the schistosome egg granuloma. Microbes Infect 1999; 1: 511-516.
3. Colley DG, Montesano MA, Freeman GL & Secor WE. Infection-stimulated or perinatally initiated idiotypic interactions can direct differential morbidity and mortality in schistosomiasis. Microbes Infect 1999; 1: 517-524.
4. Wynn TA. Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathoiogy. Microbes Infect 1999; 1: 525-534.
5. Weinstock JV, Elliott D, Metwali A et al. Immunoregulation within the granulomas of murine schistosomiasis mansoni. Microbes Infect 1999; 1: 491-498.
6. Dunne DW & Pearce EJ. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect 1999; 1: 553-560.
7. Hoffmann KF, Wynn TA & Dunne DW. Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology. Adv Parasitol 2002; 52: 265-307.
8. Cheever AW, Hoffmann KF & Wynn TA. Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today 2000; 21: 465-466.
9. Hesse M, Piccirillo CA, Belkaid Y et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166.
10. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
11. Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
12. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol, 2000; 18: 767-811.
13. Steinman RM. Some interfaces of dendritic cell biology. Apmis 2003; 111: 675-697.
14. Banchereau J, Pascual V & Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004; 20: 539-550.
15. Maldonado-Lopez R, De Smedt T, Pajak B et al. Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol 1999; 66: 242-246.
16. Shortman K & Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
17. Cervi L, MacDonald AS, Kane C, Dzierszinski F & Pearce EJ. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172: 2016-2020.
18. de Jong EC, Vieira PL, Kalinski P et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J Immunol 2002; 168: 1704-1709.
19. MacDonald AS & Pearce EJ. Cutting edge: polarized Th cell response induction by transferred antigen-pulsed dendritic cells is dependent on IL-4 or IL-12 production by recipient cells. J Immunol 2002; 168: 3127-3130.
20. Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96: 1036-1041.
21. Thomas PG, Carter MR, O Atochina et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841.
22. Sher A, Pearce E & Kaye P. Shaping the immune response to parasites: role of dendritic cells. Curr Opin Immunol 2003; 15: 421-429.
23. Liang SC, Latchman YE, Buhlmann JE et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003; 33: 2706-2716.
24. Ishida M, Iwai Y, Tanaka Y et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 2002; 84: 57-62.
25. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol, 2001; 2: 261-268.
26. Tseng SY, Otsuji M, Gorski K et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193: 839-846.
27. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4: 336-347.
28. Gorski KS, Shin T, Crafton E et al. A set of genes selectively expressed in murine dendritic cells: utility of related cis-acting sequences for lentiviral gene transfer. Mol Immunol 2003; 40: 35-47.
29. Matsumoto K, Inoue H, Nakano T et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J Immunol 2004; 172: 2530-2541.
30. Yamazaki T, Akiba H, Iwai H et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002; 169: 5538-5545.
31. Agata Y, Kawasaki A, Nishimura H et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765-772.
32. Zhang X, Schwartz JC, Guo X et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004; 20: 337-347.
33. Shinohara T, Taniwaki M, Ishida Y, Kawaichi M & Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 1994; 23: 704-706.
34. Nishimura H & Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol, 2001; 22: 265-268.
35. Youngnak P, Kozono Y, Kozono H et al. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 2003; 307: 672-677.
36. Carter LL & Carreno BM. Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation. Immunol Res 2003; 28: 49-59.
37. Rodig N, Ryan T, Allen JA et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003; 33: 3117-3126.
38. Shin T, Kennedy G, Gorski K et al. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J Exp Med 2003; 198: 31-38.
39. Smith P, Walsh CM, Mangan NE et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol 2004: 173: 1240-1248.
40. Todd CW, Goodgame RW & Colley DG. Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol 1979; 122: 1440-1446.
41. Tweardy DJ, Osman GS, el Kholy A & Ellner JJ. Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly. J Clin Microbiol 1987; 25: 768-773.
42. MacDonald AS, Straw AD, Bauman B & Pearce EJ. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001; 167: 1982-1988.
43. MacDonald AS, Straw AD, Dalton NM & Pearce EJ. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol 2002; 168: 537-540.
44. Straw AD, MacDonald AS, Denkers EY & Pearce EJ. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J Immunol 2003; 170: 727-734.
45. Thomas PG & Harn DA Jr. Immune biasing by helminth glycans. Cell Microbiol 2004; 6: 13-22.
46. van Den Biggelaar AH, Grogan JL, Filie Y et al. Chronic schistosomiasis: dendritic cells generated from patients can overcome antigen-specific T cell hyporesponsiveness. J Infect Dis 2000; 182: 260-265.
47. van der Kleij D, Latz E, Brouwers JF et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
48. Faveeuw C, Angeli V, Fontaine J et al. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol, 2002; 169: 906-912.
49. Faveeuw C, Mallevaey T, Paschinger K et al. Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice. Eur J Immunol, 2003; 33: 1271-1281.
50. Trottein F, Pavelka N, Vizzardelli C et al. A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signature. J Immunol 2004; 172: 3011-3017.
51. Chiu BC, Freeman CM, Stolberg VR, Hu JS, Komuniecki E & Chensue SW. The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function. Am J Pathol 2004; 164: 1021-1030.
52. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A & Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003; 102: 672-681.
53. Semnani RT, Sabzevari H, Iyer R & Nutman TB. Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun 2001; 69: 5813-5822.
54. Kane CM, Cervi L, Sun J et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173: 7454-7461.
55. Aksoy E, Zouain CS, Vanhoutte F et al. Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem 2005; 280: 277-283.
56. Henderson GS, Nix NA, Montesano MA et al. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol 1993; 142: 703-714.
57. Freeman GL Jr, Montesano MA, Secor WE, Colley DG, Howard MJ & Bosshardt SC. Immunopathogenesis and immunoregulation in schistosomiasis. Distinct chronic pathologic syndromes in CBA/J mice. Ann N Y Acad Sci 1996; 797: 151-165.
58. Cheever AW & Andrade ZA. Pathological lesions associated with Schistosoma mansoni infection in man. Trans R Soc Trop Med Hyg 1967; 61: 626-639.
59. Cheever AW, Kamel IA, Elwi AM, Mosimann JE & Danner R. Schistosoma mansoni and S. haematobium infections in Egypt II. Quantitative parasitological findings at necropsy. Am J Trop Med Hyg 1977; 26: 702-716.
60. Cheever AW & Yap GS. Immunologic basis of disease and disease regulation in schistosomiasis. Chem Immunol 1997; 66: 159-176.
61. van der Werf MJ, de Vlas SJ, Brooker S et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 125-139.
62. Montesano MA, Colley DG, Eloi-Santos S, Freeman GL Jr & Secor WE. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival patterns in experimental Schistosoma mansoni infections. J Exp Med 1999; 189: 637-645.
63. Montesano MA, Colley DG, Freeman GL Jr & Secor WE. Neonatal exposure to idiotype induces Schistosoma mansoni egg antigen-specific cellular and humoral immune responses. J Immunol 1999; 163: 898-905.
64. Montesano MA, Colley DG, Willard MT, Freeman GL Jr & Secor WE. Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease. J Exp Med 2002; 195: 1223-1228.
65. Boros DL & Warren KS. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970; 132: 488-507.
66. MacDonald AS, Patton EA, La Flamme AC et al. Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction. J Immunol 2002; 168: 4643-4649.
67. Rathore A, Sacristan C, Ricklan DE, Flores Villanueva PO & Stadecker MJ. In situ analysis of B7-2 costimulatory, major histocompatibility complex class II, and adhesion molecule expression in schistosomal egg granulomas. Am J Pathol 1996; 149: 187-194.
68. Carter CE & Colley DG. Partial purification and characterization of Schistosoma mansoni soluble egg antigen with Con A-Sepharose chromatography. J Immunol, 1979; 122: 2204-2209.
69. Hatachi S, Iwai Y, Kawano S et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol 2003; 30: 1410-1419.
70. Carter L, Fouser LA, Jussif J et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002; 32: 634-643.
71. Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-1034.
72. Khoury SJ & Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004; 20: 529-538.